AutoRun144  

AutomationRun144

AutoRun145  

AutomationRun145

AutoRun146  

AutomationRun146

AutoRun147  

AutomationRun147

AutoRun148  

AutomationRun148

AutoRun149  

AutomationRun149

sss

cccc  

A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease  

This is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's disease.

Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)

Are there people infected with the COVID-19 virus who have no symptoms? How is spread of COVID-19 affected by vaccination rates? Is there any hesitancy to get the vaccine and what are the reasons? This information will be used to help keep the school open and the students and staff …